317 related articles for article (PubMed ID: 17569692)
1. Undesirable nuclear reactions and induced radioactivity as a result of the use of the high-energy therapeutic beams generated by medical linacs.
Konefal A; Polaczek-Grelik K; Zipper W
Radiat Prot Dosimetry; 2008; 128(2):133-45. PubMed ID: 17569692
[TBL] [Abstract][Full Text] [Related]
2. Photonuclear dose calculations for high-energy photon beams from Siemens and Varian linacs.
Chibani O; Ma CM
Med Phys; 2003 Aug; 30(8):1990-2000. PubMed ID: 12945965
[TBL] [Abstract][Full Text] [Related]
3. The measurement of photoneutron dose in the vicinity of clinical linear accelerators.
Rivera JC; Falcão RC; Dealmeida CE
Radiat Prot Dosimetry; 2008; 130(4):403-9. PubMed ID: 18375468
[TBL] [Abstract][Full Text] [Related]
4. Correlation between radioactivity induced inside the treatment room and the undesirable thermal/resonance neutron radiation produced by linac.
Konefał A; Orlef A; Dybek M; Maniakowski Z; Polaczek-Grelik K; Zipper W
Phys Med; 2008 Dec; 24(4):212-8. PubMed ID: 18339569
[TBL] [Abstract][Full Text] [Related]
5. Neutron dose calculation at the maze entrance of medical linear accelerator rooms.
Falcão RC; Facure A; Silva AX
Radiat Prot Dosimetry; 2007; 123(3):283-7. PubMed ID: 17005540
[TBL] [Abstract][Full Text] [Related]
6. DOSE AND GAMMA-RAY SPECTRA FROM NEUTRON-INDUCED RADIOACTIVITY IN MEDICAL LINEAR ACCELERATORS FOLLOWING HIGH-ENERGY TOTAL BODY IRRADIATION.
Keehan S; Taylor ML; Smith RL; Dunn L; Kron T; Franich RD
Radiat Prot Dosimetry; 2016 Dec; 172(4):327-332. PubMed ID: 26598738
[TBL] [Abstract][Full Text] [Related]
7. Neutron measurements in a Varian 2,100C LINAC facility using a Bonner sphere system based on passive gold activation detectors.
Fernández F; Domingo C; Amgarou K; Castelo J; Bouassoule T; Garcia MJ; Luguera E
Radiat Prot Dosimetry; 2007; 126(1-4):361-5. PubMed ID: 17525060
[TBL] [Abstract][Full Text] [Related]
8. On the existence of low-energy photons (<150 keV) in the unflattened x-ray beam from an ordinary radiotherapeutic target in a medical linear accelerator.
Tsechanski A; Krutman Y; Faermann S
Phys Med Biol; 2005 Dec; 50(23):5629-39. PubMed ID: 16306657
[TBL] [Abstract][Full Text] [Related]
9. Thermal and resonance neutrons generated by various electron and X-ray therapeutic beams from medical linacs installed in polish oncological centers.
Konefał A; Orlef A; Laciak M; Ciba A; Szewczuk M
Rep Pract Oncol Radiother; 2012 Nov; 17(6):339-46. PubMed ID: 24669311
[TBL] [Abstract][Full Text] [Related]
10. Monte Carlo study of Siemens PRIMUS photoneutron production.
Pena J; Franco L; Gómez F; Iglesias A; Pardo J; Pombar M
Phys Med Biol; 2005 Dec; 50(24):5921-33. PubMed ID: 16333164
[TBL] [Abstract][Full Text] [Related]
11. Potential hazard due to induced radioactivity secondary to radiotherapy: the report of task group 136 of the American Association of Physicists in Medicine.
Thomadsen B; Nath R; Bateman FB; Farr J; Glisson C; Islam MK; LaFrance T; Moore ME; George Xu X; Yudelev M
Health Phys; 2014 Nov; 107(5):442-60. PubMed ID: 25271934
[TBL] [Abstract][Full Text] [Related]
12. Radiation safety survey on a flattening filter-free medical accelerator.
Vassiliev ON; Titt U; Kry SF; Mohan R; Gillin MT
Radiat Prot Dosimetry; 2007; 124(2):187-90. PubMed ID: 17681966
[TBL] [Abstract][Full Text] [Related]
13. Measurement of the fluence response of the GSI neutron ball dosemeter in the energy range from thermal to 19 MeV.
Fehrenbacher G; Kozlova E; Gutermuth F; Radon T; Schütz R; Nolte R; Böttger R
Radiat Prot Dosimetry; 2007; 126(1-4):546-8. PubMed ID: 17561518
[TBL] [Abstract][Full Text] [Related]
14. Contribution of activation products to occupational exposure following treatment using high-energy photons in radiotherapy.
Petrović N; Krestić-Vesović J; Stojanović D; Ciraj-Bjelac O; Lazarević D; Kovacević M
Radiat Prot Dosimetry; 2011 Jan; 143(1):109-12. PubMed ID: 20947589
[TBL] [Abstract][Full Text] [Related]
15. Activation processes in a medical linear accelerator and spatial distribution of activation products.
Fischer HW; Tabot BE; Poppe B
Phys Med Biol; 2006 Dec; 51(24):N461-6. PubMed ID: 17148816
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the photoneutron field produced in a medical linear accelerator.
Kim HS; Park YH; Koo BC; Kwon JW; Lee JS; Choi HS
Radiat Prot Dosimetry; 2007; 123(3):323-8. PubMed ID: 17077093
[TBL] [Abstract][Full Text] [Related]
17. Health physics aspects of neutron activated components in a linear accelerator.
Guo S; Ziemer PL
Health Phys; 2004 May; 86(5 Suppl):S94-S102. PubMed ID: 15069298
[TBL] [Abstract][Full Text] [Related]
18. Comparison of activation products and induced dose rates in different high-energy medical linear accelerators.
Fischer HW; Tabot B; Poppe B
Health Phys; 2008 Mar; 94(3):272-8. PubMed ID: 18301101
[TBL] [Abstract][Full Text] [Related]
19. Experimental determination of peripheral doses for different IMRT techniques delivered by a Siemens linear accelerator.
Wiezorek T; Voigt A; Metzger N; Georg D; Schwedas M; Salz H; Wendt TG
Strahlenther Onkol; 2008 Feb; 184(2):73-9. PubMed ID: 18259698
[TBL] [Abstract][Full Text] [Related]
20. Multileaf shielding design against neutrons produced by medical linear accelerators.
Rebello WF; Silva AX; Facure A
Radiat Prot Dosimetry; 2008; 128(2):227-33. PubMed ID: 17569690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
